🔥 Top Dips 📋 My Watchlists 📊 Momentum 📈 Stocks 🏛️ ETFs 🛢️ Commodities ₿ Crypto

IBRX Daily Technical Analysis

Timeframe: DailyWeeklyMonthly

Immunitybio Inc

Commercial-stage biotechnology company that develops next-generation therapies designed to bolster the natural immune system to defeat cancers and infectious diseases.

Last price: $8.45 Value score: 35.56 Short-term sentiment: Bearish Long-term sentiment: Bullish Last updated: 2026-03-09T21:05:46.852Z

IBRX Technical Analysis Summary

IBRX has experienced a structural shift, breaking out of a long-term base on massive volume and establishing a strong primary uptrend. Currently, the stock is undergoing a sharp, necessary correction to digest the parabolic move to $13, leading to bearish short-term momentum. Long-term investors should watch for the price to establish a higher low, potentially near the $6.00-$7.00 range or the 50-day SMA, to signal the continuation of the broader bullish trend.

Included In Lists

Related Tickers of Interest

IBRX Daily Chart

Daily candlestick price chart for IBRX as of 2026-03-09T21:05:46.852Z, showing 20-, 50-, and 200-period SMAs, Bollinger Bands, volume, MACD, RSI, and the current price line with top status bar.
Daily candlestick price chart for IBRX as of 2026-03-09T21:05:46.852Z, showing 20-, 50-, and 200-period SMAs, Bollinger Bands, volume, MACD, RSI, and the current price line with top status bar.

Sentiment

Short-term Sentiment (days to weeks): Bearish

The price is currently in a sharp pullback from recent highs, trading slightly below the 20-day SMA. Momentum indicators are negative, with the RSI declining towards the midline and the MACD line having crossed below the signal line alongside an expanding negative histogram.

Long-term Sentiment (weeks to months): Bullish

The long-term trend has shifted strongly bullish following a massive breakout from a multi-month consolidation base. This is confirmed by the 50-day SMA crossing above the 200-day SMA (Golden Cross) and both moving averages sloping sharply upwards.

Report Metadata

Support Price Levels

Level Range Strength Notes
$7.00 $6.50 - $7.50 Weak Area of minor consolidation during the recent rapid ascent and an approximate 50% retracement of the breakout move.
$5.75 $5.50 - $6.00 Strong Major prior resistance zone that triggered the breakout, now aligning closely with the rapidly rising 50-day SMA.

Resistance Price Levels

Level Range Strength Notes
$9.25 $9.00 - $9.50 Weak Immediate resistance area near the 20-day SMA and recent minor lower highs during the current pullback.
$12.50 $12.00 - $13.00 Strong The recent peak and major swing high; psychological resistance area.

Potential Chart Patterns in Formation

Strength Pattern Signal Target Details
Strong Base Breakout Bullish N/A The stock broke out of a prolonged, multi-month consolidation phase (below $4.00) on exceptionally high volume, initiating a new major uptrend.
Weak Bull Flag (Forming) Bullish N/A The current sharp, lower-volume pullback following the massive vertical move (flagpole) resembles the formation of a bull flag pattern. It requires stabilization and an upward break to confirm.

Frequently Asked Questions about IBRX

What is the current sentiment for IBRX?

The short-term sentiment for IBRX is currently Bearish because The price is currently in a sharp pullback from recent highs, trading slightly below the 20-day SMA. Momentum indicators are negative, with the RSI declining towards the midline and the MACD line having crossed below the signal line alongside an expanding negative histogram.. The long-term trend is classified as Bullish.

What are the key support levels for IBRX?

StockDips.AI has identified key support levels for IBRX at $7.00 and $5.75. These levels may represent potential accumulation zones where buying interest could emerge.

Is IBRX in a significant dip or a Value Dip right now?

IBRX has a Value Score of 36/100. It is not currently flagged as a significant dip in the Top Dips list. It is not listed as a Value Dip because the long-term sentiment or value-score threshold does not qualify.

View the full interactive analysis on StockDips.AI.